|
|
|
|
|||||
|
|
|
Here are three stocks with buy rank and strong value characteristics for investors to consider today, April 30th:
SK Telecom Co. SKM: This company which is the world's first commercial CDMA digital cellular service, carries a Zacks Rank #1 (Strong Buy), and has witnessed the Zacks Consensus Estimate for its current year earnings increasing 7.5% over the last 60 days.
SK Telecom Co., Ltd. price-consensus-chart | SK Telecom Co., Ltd. Quote
SK Telecom has a price-to-earnings ratio (P/E) of 8.61 compared with 10.5 for the industry. The company possesses a Value Score of A.
SK Telecom Co., Ltd. pe-ratio-ttm | SK Telecom Co., Ltd. Quote
Takeda Pharmaceutical Co. TAK: This research-based pharmaceutical company, engaged in manufacturing, marketing, and importing/exporting pharmaceutical drugs, carries a Zacks Rank #1, and has witnessed the Zacks Consensus Estimate for its current year earnings increasing 1.9% over the last 60 days.
Takeda Pharmaceutical Co. price-consensus-chart | Takeda Pharmaceutical Co. Quote
Takeda Pharmaceutical has a price-to-earnings ratio (P/E) of 9.08 compared with 9.30 for the industry. The company possesses a Value Score of A.
Takeda Pharmaceutical Co. pe-ratio-ttm | Takeda Pharmaceutical Co. Quote
PHINIA Inc. PHIN: This company which is a premium solutions and components provider of manufacturing expertise, carries a Zacks Rank #1, and has witnessed the Zacks Consensus Estimate for its current year earnings increasing 3.2% over the last 60 days.
PHINIA Inc. price-consensus-chart | PHINIA Inc. Quote
PHINIA has a price-to-earnings ratio (P/E) of 9.75 compared with 44.70 for the industry. The company possesses a Value Score of A.
PHINIA Inc. pe-ratio-ttm | PHINIA Inc. Quote
See the full list of top ranked stocks here.
Learn more about the Value score and how it is calculated here.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
This article originally published on Zacks Investment Research (zacks.com).
| Apr-30 | |
| Apr-30 | |
| Apr-30 | |
| Apr-30 | |
| Apr-30 | |
| Apr-30 | |
| Apr-30 | |
| Apr-30 | |
| Apr-29 | |
| Apr-28 | |
| Apr-25 | |
| Apr-25 | |
| Apr-25 | |
| Apr-25 | |
| Apr-24 |
Join thousands of traders who make more informed decisions with our premium features. Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite